What is the half-life of Escitalopram?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The half-life of escitalopram is approximately 27-32 hours. This means it takes about 1-1.5 days for half of the drug to be eliminated from the body. For most patients, this translates to a once-daily dosing schedule, typically 10-20 mg taken in the morning or evening. The long half-life helps maintain steady blood levels of the medication over 24 hours, which contributes to its effectiveness in treating depression and anxiety disorders. Due to this extended half-life, it takes about 1-2 weeks for escitalopram to reach steady-state concentrations in the body when starting treatment, as noted in studies such as 1. Similarly, it may take several days to a week for the drug to be fully eliminated from the system after discontinuation. The long half-life also means that if a dose is missed, the impact on blood levels is less immediate compared to medications with shorter half-lives. However, patients should still aim to take their dose at the same time each day for optimal effect. In elderly patients or those with liver impairment, the half-life may be slightly longer, potentially necessitating dose adjustments, as considered in guidelines like 1 and 1. Always consult with a healthcare provider for personalized dosing information. Some key points to consider when prescribing escitalopram include:

  • Starting with a low dose and gradually increasing as needed and tolerated
  • Monitoring for symptoms of serotonin syndrome, especially when combining with other serotonergic drugs
  • Being aware of potential drug interactions, particularly with drugs that prolong the QT interval
  • Considering the patient's medical history, including any history of suicidal thoughts or behavior, and closely monitoring their condition.

From the FDA Drug Label

  1. 3 Pharmacokinetics ... Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27-32 hours. The half-life of escitalopram is 27-32 hours 2.
  • The half-life may be increased in elderly subjects, by approximately 50%.
  • No adjustment of dosage is needed in adolescent patients.

From the Research

Half-Life of Escitalopram

  • The half-life of escitalopram is approximately 27-33 hours, as reported in studies 3, 4, 5.
  • This half-life is consistent with once-daily administration, allowing for steady-state concentrations to be achieved within 7-10 days of administration 3.
  • The pharmacokinetics of escitalopram are linear and dose-proportional, with the area under the plasma concentration-time curve and maximum observed plasma concentration increasing proportionally with dose 4, 5.
  • The half-life of escitalopram is not affected by food intake, and it has a high absolute bioavailability, making it suitable for oral administration 4, 6.

Comparison with Other SSRIs

  • Escitalopram has a half-life similar to other SSRIs, such as citalopram, but differs from fluoxetine, which has a longer half-life of 2-4 days and an active metabolite with a half-life of 7-15 days 7.
  • The pharmacokinetic properties of escitalopram, including its half-life, make it a suitable option for the treatment of depression and anxiety disorders, with a low potential for drug interactions and a favorable safety profile 3, 5, 6.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.